We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CRIN:XETRUniCredit S.p.A. Analysis

Data as of 2026-06-14 - not real-time

€72.96

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

UniCredit (CRIN) is trading at €72.96, comfortably above its 20‑day (€72.62), 50‑day (€69.76) and 200‑day (€67.74) moving averages, indicating a bullish price backdrop. Technical signals are mixed: while the overall trend is bullish and the RSI sits at a neutral 55, the MACD histogram is negative and volume is slipping, suggesting short‑term caution. On the fundamentals side, the stock looks significantly undervalued with a trailing PE of 10 versus an industry average of 16.8, a robust operating margin of 62%, and a profit margin of 45%. The latest earnings call highlighted a 16% YoY profit jump to €3.2 bn and a 26% return on tangible equity, reinforcing the strength of core earnings. Dividend appeal is strong, offering a 4.32% yield on a 40% payout ratio, and the balance sheet shows ample cash (€113 bn) relative to debt (€133 bn). However, the 30‑day volatility of ~31% and declining trading volume signal heightened market risk, while the banking sector faces medium regulatory and geographic exposure. Overall, the stock presents a compelling value case with solid earnings and dividend support, but investors should watch for short‑term technical weakness.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above key moving averages supports bullish bias
  • Bearish MACD histogram and decreasing volume raise caution
  • Strong dividend yield provides downside protection

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued PE relative to peers
  • Record earnings and rising profit margins
  • Attractive dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistently high ROE and operating margins
  • Low beta indicating defensive profile
  • Solid cash position and ongoing dividend growth

Key Metrics & Analysis

Financial Health

Revenue Growth6.40%
Profit Margin44.62%
P/E Ratio10.0
ROE16.98%
ROA1.34%
P/B Ratio1.6
Industry P/E16.8

Technical Analysis

TrendBullish
RSI54.9
Support€70.10
Resistance€74.88
MA 20€72.62
MA 50€69.76
MA 200€67.74
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

GradeUndervalued
TypeValue
Dividend Yield4.32%

Risk Assessment

Beta0.38
Volatility30.84%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.